Dual specificity phosphatases in prostate cancer

Yke Jildouw Arnoldussen1, Fahri Saatcioglu

  • 1Department of Molecular Biosciences, University of Oslo, Blindern, 0316 Oslo, Norway.

Insights

Dual specificity phosphatases (DUSPs) impact prostate cancer development by regulating mitogen-activated protein kinase (MAPK) pathways. Understanding DUSP roles in MAPK signaling is crucial for determining their effect on prostate carcinogenesis and disease outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mitogen-activated protein kinase (MAPK) pathways regulate crucial cellular processes like growth, differentiation, and apoptosis.
  • MAPK dysregulation is implicated in various cancers, including prostate cancer, the most common non-cutaneous cancer in men.
  • Dual specificity phosphatases (DUSPs), including MAPK phosphatases (MKPs) and atypical DUSPs, are key regulators of MAPK activity.

Purpose of the Study:

  • To review the emerging roles of DUSPs in regulating MAPK pathways within the context of prostate cancer.
  • To discuss the potential impact of DUSPs on prostate carcinogenesis and disease progression.
  • To highlight the current understanding and remaining questions regarding DUSP mechanisms in prostate cancer.

Main Methods:

  • Literature review of studies investigating MAPK pathways and DUSPs in prostate cancer.
  • Analysis of existing evidence on DUSP expression alterations in prostate cancer.
  • Synthesis of findings on the correlation between DUSP expression, cell survival, and cell death in prostate cancer cells.

Main Results:

  • MAPK pathway alterations are observed in prostate cancer.
  • Evidence suggests DUSPs play significant roles in modulating MAPK signaling in prostate cancer.
  • Changes in DUSP expression correlate with prostate cancer cell survival and death, though mechanisms are not fully elucidated.

Conclusions:

  • DUSPs are emerging as critical regulators in prostate cancer, influencing disease outcome through MAPK pathway modulation.
  • Further research is needed to establish consistent mechanisms by which DUSPs affect prostate carcinogenesis.
  • Understanding DUSP functions offers potential therapeutic targets for prostate cancer treatment.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...